Moxinix DF
(Moxifloxacin 0.5% + Difluprednate 0.05%)
Moxifloxacin offers
- Topical Moxifloxacin alone can prevent Endophthalmities
- Only anti-infective to achieve therapeutic levels in vitreous humour
- Promotes faster corneal wound healing & Re-Epithelizaton
- Effective against Atypical Mycobacterium
Difluprednate Ophthalmic Emulsion
- 7.4 fold higher corneal penetration
- 5.7 fold higher aqueous penetration
- Anti-Inflamatory effect at half the dose of Prednisolone
- Safety & Effectively reduces anterior chamber inflammation & pain
- Does not require shaking unlike Suspension with enhanced safety & efficacy